Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06909331 · ClinicalTrials.gov registry record · NA
Accuracy of Current Techniques in Quantifying Ketone Levels
A NA study of Placebo - Control and Exogenous Ketone Salt, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06909331: Completed NA study of Placebo - Control and Exogenous Ketone Salt, sponsored by Augusta University.
NCT06909331 is a NA study of Placebo - Control and Exogenous Ketone Salt that has completed, run by Augusta University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06909331, a NA study of Placebo - Control and Exogenous Ketone Salt, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the accuracy of current measuring techniques used to detect physiological ketone levels.
Primary Outcome
Circulating beta-hydroxybutyrate levels measured by ketone meters and GC/MS
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Exogenous ketone salt
- DIETARY_SUPPLEMENT Placebo drink solution
Study Locations (1)
Georgia
- Augusta University - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2019-12-15 |
| Phase | NA |
What the finished NCT06909331 record still lists
NCT06909331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Placebo - Control appearing as the primary indexed condition, and to 2 interventions - of which Exogenous ketone salt is the first listed.
NCT06909331 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06909331 about?
NCT06909331 is a clinical study titled "Accuracy of Current Techniques in Quantifying Ketone Levels". The purpose of this study is to determine the accuracy of current measuring techniques used to detect physiological ketone levels.
What is the current status of trial NCT06909331?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-01-15. Estimated completion is 2019-12-15.
What conditions does trial NCT06909331 study?
This clinical trial studies the following conditions: Placebo - Control, Exogenous Ketone Salt.
What interventions are being tested in trial NCT06909331?
The interventions under investigation include: Exogenous ketone salt (DIETARY_SUPPLEMENT), Placebo drink solution (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06909331?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06909331 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Placebo - Control
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06909331's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI